Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Pilot Testing of Peak Alpha Frequency Stability During Repetitive Transcranial Magnetic Stimulation

Bibliographic Data

ID15523558
AuthorsNicholas J Petrosino (0000-0002-1339-2096, Butler Hospital), Amin Zandvakili (0000-0003-1554-8370, Providence VA Medical Center), Linda L Carpenter (0000-0002-9651-3307, Butler Hospital), Noah S Philip (0000-0002-4889-8775, Butler Hospital, corresponding author)
Year2018
Volume9
Pages605-605
Publication date2018-11-20
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2018.00605
PMID30515110
OpenAlexW2901431030
LanguageEN
References cited2

Over half of those diagnosed with post-traumatic stress disorder (PTSD) have comorbid major depressive disorder (MDD), and rates are even higher among military veterans. Transcranial magnetic stimulation (TMS) may be a safe and efficacious treatment for PTSD, both with and without comorbid MDD. Still, the mechanism of action of TMS is not fully understood, and it remains unclear which stimulation techniques (e.g., target regions, pulse strength/frequency, waveform) optimize treatment for these patients. Recent research indicated that a patient's unique individualized alpha frequency (IAF) may be used to guide brain stimulation treatment, and emerging data suggests that stimulation synchronized to the IAF may be efficacious for MDD. However, to our knowledge there are no studies to date that evaluate the stability of IAF over time in patients with comorbid PTSD and MDD. To this end, we used an eight-lead electroencephalography (EEG) system to record IAF before and after a course of TMS. Stimulation parameters were informed by prior studies of TMS for comorbid PTSD and MDD and included 5 Hz TMS to the left dorsolateral prefrontal cortex, at 120% of motor threshold, 3,000-4,000 pulses per session for up to 40 sessions. We tested whether IAF was changed with a course of TMS therapy and evaluated whether IAF predicted clinical outcomes. We observed no significant changes in IAF from baseline to post-treatment, and there was no relationship between IAF and clinical symptom change. These data demonstrate the stability of IAF with TMS and indicate its utility as a trait marker for future brain stimulation studies. This work does not support the use of IAF as predictor of clinical response to TMS as administered

Audiology · Brain stimulation · Cognition · Deep transcranial magnetic stimulation · Dorsolateral prefrontal cortex · Electroconvulsive therapy · Electroencephalography · Major depressive disorder · Physical medicine and rehabilitation · Prefrontal cortex · Psychiatry · Stimulation · Transcranial magnetic stimulation · Functional Brain Connectivity Studies · Medicine · Neural and Behavioral Psychology Studies · Neuroscience · Psychology · Transcranial Magnetic Stimulation Studies

  • Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care

    Charles W Hoge, Carl A Castro et al.•New England Journal of Medicine•2004

Citation velocityhistorical
Highly citedNo

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae